These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The positive effects of growth hormone-releasing peptide-6 on weight gain and fat mass accrual depend on the insulin/glucose status. Granado M, García-Cáceres C, Frago LM, Argente J, Chowen JA. Endocrinology; 2010 May; 151(5):2008-18. PubMed ID: 20219977 [Abstract] [Full Text] [Related]
3. Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats. Granado M, Chowen JA, García-Cáceres C, Delgado-Rubín A, Barrios V, Castillero E, Argente J, Frago LM. Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):67-75. PubMed ID: 19540304 [Abstract] [Full Text] [Related]
4. Death of hypothalamic astrocytes in poorly controlled diabetic rats is associated with nuclear translocation of apoptosis inducing factor. García-Cáceres C, Lechuga-Sancho A, Argente J, Frago LM, Chowen JA. J Neuroendocrinol; 2008 Dec 15; 20(12):1348-60. PubMed ID: 19094082 [Abstract] [Full Text] [Related]
6. Reduction in the number of astrocytes and their projections is associated with increased synaptic protein density in the hypothalamus of poorly controlled diabetic rats. Lechuga-Sancho AM, Arroba AI, Frago LM, García-Cáceres C, de Célix AD, Argente J, Chowen JA. Endocrinology; 2006 Nov 15; 147(11):5314-24. PubMed ID: 16873533 [Abstract] [Full Text] [Related]
7. Anatomically specific changes in the expression of somatostatin, growth hormone-releasing hormone and growth hormone receptor mRNA in diabetic rats. Busiguina S, Argente J, García-Segura LM, Chowen JA. J Neuroendocrinol; 2000 Jan 15; 12(1):29-39. PubMed ID: 10692141 [Abstract] [Full Text] [Related]
9. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S. J Endocrinol; 2006 Feb 15; 188(2):263-70. PubMed ID: 16461552 [Abstract] [Full Text] [Related]
10. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice. Park S, Peng XD, Frohman LA, Kineman RD. Neuroendocrinology; 2005 Feb 15; 81(6):360-71. PubMed ID: 16244497 [Abstract] [Full Text] [Related]
12. The number of lactotrophs is reduced in the anterior pituitary of streptozotocin-induced diabetic rats. Arroba AI, Frago LM, Pañeda C, Argente J, Chowen JA. Diabetologia; 2003 May 15; 46(5):634-8. PubMed ID: 12743699 [Abstract] [Full Text] [Related]
13. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW, Gilbert JM, Berelowitz M. Endocrinology; 1990 Jan 15; 126(1):53-61. PubMed ID: 1967164 [Abstract] [Full Text] [Related]
17. GH responses to GHRH and GHRP-6 in Streptozotocin (STZ)-diabetic rats. Diz Chaves Y, Spuch Calvar C, Pérez Tilve D, Mallo Ferrer F. Life Sci; 2003 Nov 14; 73(26):3375-85. PubMed ID: 14572879 [Abstract] [Full Text] [Related]
18. Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro. Qiu WC, Wang ZG, Wang WG, Yan J, Zheng Q. Chin Med J (Engl); 2008 Jul 05; 121(13):1183-8. PubMed ID: 18710636 [Abstract] [Full Text] [Related]